Top brokers name 3 ASX shares to buy today

Many of Australia’s top brokers have been busy adjusting their discounted cash flow models and recommendations again this week.

Unsurprisingly, this has led to countless buy, hold, and sell recommendations.

Three buy recommendations that caught my eye are listed below. Here’s why these brokers are bullish on them:

Magellan Financial Group Ltd (ASX: MFG)

According to a note out of Credit Suisse, its analysts have upgraded the shares of this fund manager to an outperform rating from neutral and increased the price target on them to $31.00. The broker made the move after upgrading its earnings estimates following the release of a strong quarterly fund performance update this morning. The broker expects first-half performance fees to be over $30 million if this level of performance can be maintained through the current quarter. I think Credit Suisse is spot on and Magellan would be well worth a closer look.

Orora Ltd (ASX: ORA)

A note out of Goldman Sachs reveals that its analysts have added this packaging company to its conviction buy list with an increased price target of $4.24. According to the note, the broker thinks that Orora is “the complete package” and the best option for investors in the industry. It feels that a recent pullback in its share price on the back of input cost concerns has been unwarranted and has predicted solid earnings growth over the next few years. The broker has forecast an EBIT compound annual growth rate of 9.7% between FY 2018 and FY 2021, including acquisitions. I agree with Goldman and would suggest investors take a closer look at Orora after the recent share price weakness.

Qantas Airways Limited (ASX: QAN)

Analysts at Macquarie have retained their outperform rating but cut the price target on this airline’s shares slightly to $7.30. In the note the broker points out that Qantas’ shares are trading at a significant discount to many of its peers based on its forward enterprise value/operating earnings ratio. This is despite the domestic market remaining solid and the company experiencing improved profitability from its international business. Overall, despite rising fuels costs, the broker sees a lot of value in its shares and I would have to agree.


Here's a fourth stock that has been named as a buy this month. I would suggest investors act fast before its shares potentially take off.

Top Australian Stock Picker Just Issued Rare “Double Down” Buy Alert

Discover why this legendary Australian stock-picker just issued a “Double Down” buy alert to his exclusive group of insiders… and why he’s convinced this might be the single most attractive entry point for years to come.

Simply click here to get started and access our secure sign-up page.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!